AROG Pharmaceuticals is a privately held, late-stage biopharmaceutical company based in Dallas, Texas. Founded in 2010, AROG is dedicated to improving the lives of cancer patients by developing treatments for rare cancers with high unmet needs. With a focus on indications such as acute myeloid leukemia (AML) and gastrointestinal stromal tumors (GIST), AROG has conducted numerous clinical trials and obtained exclusive worldwide rights to patented compounds, including crenolanib, from Pfizer.
Driven by the mission to bring cures to those in need, AROG has assembled a team of experienced leaders who are committed to executing the company's vision. With a pipeline of selective and purpose-built medicines, AROG aims to maximize the inhibition of intended targets, offering hope and potential breakthroughs for cancer patients worldwide.
Generated from the website